The CVD Academy is supported by unrestricted grants from Bayer, Daiichi-Sankyo, Novo Nordisk and Novartis who have had no input into the faculty or content.
Sponsored by Boehringer-Ingelheim & Lilly Diabetes Alliance (The Alliance). BI-Lilly Alliance did not have any involvement or influence in selection of faculty, development of agenda or contents for these educational resources.
WHAT IS THE CVD ACADEMY?
Despite improvements in primary care management of many cardiovascular conditions there is still considerable practice variation across the UK. The priorities identified by NHSE and experts in CVD and Public Health are detection and management of hypertension, atrial fibrillation, lipid disorders including familial hypercholesterolaemia (FH) and heart failure (HF). The National CVD Prevention programme aims to close the detection gap in these CVD areas, offer protection against CV events and other morbidities and perfect treatments by optimising evidence-based therapies in primary care. The emerging Primary Care Networks (PCNs) will have a remit to implement the National CVD Prevention Audits for the benefit of patients, and the local health economy, and reduce health inequalities.
As a society we have recognised this skill gap within primary care and are therefore delighted to be able to launch our Primary Care Cardiovascular Society CVD Academy. The Academy provides PCCS members with a variety of different educational resources in cardiovascular disease. We have 14 different categories surrounding CVD, the content is divided into modules, and a resources page features latest guidelines and relevant publications. Each module is CPD accredited and you can download a certificate directly from the Academy. In addition to these modules, recordings of all four sessions from the spring conference, ‘Current Conversations in Cardiovascular Disease’, are available.
CVD ACADEMY TOPICS:
- Cardiovascular risk assessment & cardiovascular prevention
- Atrial fibrillation and arrhythmia
- Heart failure
- Coronary artery disease
- PAD/aortic dissection/adult congenital heart disease
- Cardio-renal-metabolic/Chronic kidney disease
- Heart valve disease (COMING SOON)
- Thrombosis (COMING SOON)
- Basic cardiology (COMING SOON)
- Stroke/TIA (COMING SOON)
- Cardiac investigations (COMING SOON)
- Syncope (COMING SOON)
"In Leeds we have been using the PCCS Academy ‘Module 5: Atrial Fibrillation and flutter’ to enhance PCN pharmacist learning and development around the management of anticoagulation for AF. The PCCS modules are accessible and concise. This supports learning for early career pharmacists new to AF management, right through to experienced practitioners who need a quick update and some CPD following the release of the new NICE AF guidance."
- Advanced Pharmacist, Leeds